The hitmaker, 50, was a guest on the show to promote his biopic Better Man, and during the interview, discussed the appearance of Jonno Davies, who plays his younger self.
The weight-loss market began feeling some growing pains as the year ended, creating more wariness for the upcoming year. For 2025, competition and supply constraints are areas to watch.
A new technology is disrupting the economy. Even experts don’t entirely understand how it works, its full range of uses and ...
The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
Biopharmaceutical firms engaged in developing weight-loss drugs were rewarded rather significantly in 2024. It’s what helped ...
A clinical stage biopharma firm in Miami is slashing its headcount after selling its female condom business to an investment ...
The female hormone estrogen appears to promote binge drinking in women, a new mouse study published recently in the journal ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
It hasn’t been a smooth year for the two pharma giants, but events in the fourth quarter widened the gap between them.
Check out all our end-of-year content—the latest Heart Sounds podcast reviews the reporters’ own favorite stories for 2024, ...
In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback